Dicot Pharma AB (STO:DICOT)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.352
-0.008 (-2.09%)
At close: Dec 4, 2025
60.00%
Market Cap 711.31M
Revenue (ttm) n/a
Net Income (ttm) -84.10M
Shares Out 2.01B
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 8,677,414
Average Volume 12,660,576
Open 0.359
Previous Close 0.360
Day's Range 0.343 - 0.368
52-Week Range 0.200 - 1.180
Beta 1.88
RSI 35.95
Earnings Date Feb 18, 2026

About Dicot Pharma AB

Dicot Pharma AB engages in the development of pharmaceutical products in Sweden. It is developing LIB-01 for the treatment of erectile dysfunction and premature ejaculation. The company was formerly known as Dicot AB (publ) and changed its name to Dicot Pharma AB in May 2024. Dicot Pharma AB was incorporated in 2015 and is based in Uppsala, Sweden. [Read more]

Sector Healthcare
Founded 2015
Employees 3
Stock Exchange Nasdaq Stockholm
Ticker Symbol DICOT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.